Ocean Biomedical, Inc. (OCEA): Nasdaq/NYSE listing notice — Ocean Biomedical receives Nasdaq delisting notice for failure to hold annual meeting

Ocean Biomedical, Inc.

Nasdaq notified Ocean Biomedical on Jan 7, 2025, that it failed to hold an annual meeting within 12 months of FY2023 end, violating Rule 5620(a).
This deficiency serves as an additional basis for delisting; the Nasdaq Hearings Panel will consider it in the ongoing listing review.
Company must submit views by Jan 14, 2025, and plans to hold annual meeting no later than March 31, 2025.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Ocean Biomedical, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a), 5810(c)(2)(G)

Exact text from the filing

January 7, 2025, the Company received a notice from Nasdaq that since the Company had not yet held an annual meeting of shareholders within twelve months of the Company’s fiscal year ended December 31, 2023, it no longer complies with the Listing Rules (the “Rules”) for continued listing.( Listing Rules 5620(a) and 5810(c)(2)(G)). Accordingly, this matter serves as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market. This is formal notification that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s co

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Ocean Biomedical, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a), 5810(c)(2)(G)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: shareholders
Rules: 5620(a), 5810(c)(2)(G)

Exact text from the filing

January 7, 2025, the Company received a notice from Nasdaq that since the Company had not yet held an annual meeting of shareholders within twelve months of the Company’s fiscal year ended December 31, 2023, it no longer

View on SEC.gov

Browse all listing & compliance notices →

Ocean Biomedical, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-002237

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.